Free shipping on orders over $150  |  All products third-party tested for 99%+ purity Shop Now

CJC-1295 vs AOD-9604: Which Is Better?

CJC-1295 vs AOD-9604 comparison. Growth hormone secretagogue (GHRH analog) vs Fat-loss peptide. When to use each and how they differ.

Reviewed by Form Blends Medical Team|Updated March 2026

CJC-1295 vs AOD-9604: Which Is Better?

Quick Answer: CJC-1295 vs AOD-9604 compares a two peptides that both affect body composition but through different mechanisms. CJC-1295 stimulates full GH release, providing broad benefits including fat metabolism, lean mass support, sleep, and recovery. AOD-9604 is a GH fragment targeting fat oxidation specifically without other GH effects. CJC-1295 is broader; AOD-9604 is more targeted for fat loss .

Head-to-Head Comparison

CJC-1295 vs AOD-9604
FactorCJC-1295AOD-9604
CategoryGrowth hormone secretagogue (GHRH analog)Fat-loss peptide
Primary roleExtended GH stimulationLipolysis stimulation
MechanismGHRH receptor activation with extended half-life (DAC version)GH fragment-mediated fat oxidation without growth effects
Best forGH optimization, body composition, sleep, recoveryStubborn fat reduction, body composition
AdministrationSC injection daily (often with Ipamorelin)SC injection daily
EvidenceClinical GH elevation dataPreclinical + limited clinical

When to Choose CJC-1295

  • GH optimization is your primary goal
  • You want extended gh stimulation
  • GH optimization, body composition, sleep, recovery are your focus areas

When to Choose AOD-9604

  • Stubborn fat reduction is your primary goal
  • You want lipolysis stimulation
  • Stubborn fat reduction, body composition are your focus areas

Can You Use Both?

Yes. CJC-1295 and AOD-9604 work through independent mechanisms and do not interfere with each other. They can be combined when your health goals span both extended gh stimulation and lipolysis stimulation. Your physician can design a protocol that incorporates both compounds with appropriate timing and dosing.

Frequently Asked Questions

Which has stronger evidence?

CJC-1295 has clinical gh elevation data. AOD-9604 has preclinical + limited clinical. The strength of evidence depends on the specific application you are considering.

Which should I start with?

Start with whichever addresses your most pressing health concern. If you need extended gh stimulation, start with CJC-1295. If you need lipolysis stimulation, start with AOD-9604. A physician can help you prioritize.

Find Your Optimal Protocol

At Form Blends, our physicians evaluate your health goals and recommend the most effective peptide approach, whether single compounds or strategic combinations.

Schedule Your Free Consultation

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a licensed healthcare provider. Individual results may vary.

Related Articles